Posted on 1/21/21
CorMedix to Begin Trading on the Nasdaq Stock Exchange
BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 1/21/21
Salarius Pharmaceuticals Regains Compliance with Nasdaq
HOUSTON, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid . . .
Posted on 1/21/21
Inovio Pharma Secures $150.5M Capital Raise
Inovio Pharmaceuticals (NASDAQ:INO) has priced its public offering of 17.7M common shares at $8.50/share, for expected gross proceeds of ~$150.5M.Underwriters' over-allotment is an additional ~2.7M shares.Net . . .
Posted on 1/21/21
Bridges Consumer Healthcare Portfolio Company of Charlesbank Capital Partners Acquires Clarion Brands from Swander Pace Capital
CHATTANOOGA, Tenn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Bridges Consumer Healthcare LLC has announced the acquisition of Clarion Brands, LLC, from Swander Pace Capital, adding to its . . .
Posted on 1/21/21
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
Vaccine partners Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) released information today that provides new evidence that their COVID-19 vaccine is effective against the B.1.1.7 variant that was . . .
Posted on 1/21/21
Moderna Investigating Reports of Allergic Reactions to Its Coronavirus Vaccine
Moderna (NASDAQ:MRNA) said on Tuesday that it was investigating a few cases in which patients appeared to have allergic reactions to its coronavirus vaccine. All of . . .
Posted on 1/21/21
Editas Medicine Prices of Offering of Common Stock
CAMBRIDGE, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering . . .
Posted on 1/21/21
Chimerix Prices Public Offering of Common Stock
DURHAM, N.C., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and . . .
Posted on 1/21/21
Greater Cannabis Company Announces Retirement of Remaining Convertible Debt
BALTIMORE, MD, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Greater Cannabis Company (GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid . . .
Posted on 1/21/21
Aclaris Prices Public Offering of Common Stock
WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today . . .
Posted on 1/21/21
INOVIO Proposes Public Offering of Common Stock
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including . . .
Posted on 1/21/21
OncoSec Medical Proposes Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
INOVIO Prices Public Offering of Common Stock
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including . . .
Posted on 1/21/21
Maryland’s COVID-19 Hospitalizations Dip Slightly, State Records 38 New Deaths
There are currently 1,858 Marylanders hospitalized with coronavirus, with 17 fewer patients than on Tuesday.Of the state’s current COVID-19 patients, 1,438 are in acute care and . . .
Posted on 1/21/21
A User Experience Diagnosis of the COVID-19 Vaccine Rollout
The U.S. is leading the world in COVID-19 vaccines administered — as of Tuesday, we were leading China by over
Posted on 1/21/21
Who, What, Why, When and Where of COVID Vaccines
January 26, 5:00 p.m. Join The Associated, its network of agencies and LifeBridge Health in a virtual town hall discussion on the rollout of the COVID-19 vaccines . . .
Posted on 1/20/21
Haemonetics To Acquire Cardiva Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered . . .
Posted on 1/20/21
Turnstone Biologics Acquires Novel Cell Therapy Platform
NEW YORK--(BUSINESS WIRE)--Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced that it has acquired California-based Myst Therapeutics, a privately . . .
Posted on 1/20/21
Aldeyra Therapeutics Closes of Public Offering of Common Stock
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
Posted on 1/20/21
Syros Prices of $75.6 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, announced today that it has priced an . . .
Posted on 1/20/21
Aclaris Prices of Public Offering of Common Stock
WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today . . .
Posted on 1/20/21
Cerecor Purchase Additional Shares of Common Stock Bringing Public Offering Proceeds to $40.7 Million
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and . . .
Posted on 1/20/21
AVEO Oncology Announces Incremental $10M Loan
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that it has received a commitment letter for an incremental $10 million loan from Hercules Capital, Inc. (NYSE: HTGC) . . .
Posted on 1/20/21
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss upcoming . . .
Posted on 1/20/21
Where Will Pfizer Be in 5 Years?
Investors threw piles of money at up-and-coming biotechs last year, and that was before the coronavirus pandemic accelerated the trend even further. This capital isn't taking . . .
